Cargando…

The Impact of HCV Infection Duration on HIV Disease Progression and Response to cART amongst HIV Seroconverters in the UK

INTRODUCTION: The effect of HCV infection on HIV disease progression remains unclear; the effect of HCV infection duration on HIV disease progression is unknown. METHODS: We used data from a cohort of HIV seroconverters to investigate the effect of HCV infection duration on time from HIV seroconvers...

Descripción completa

Detalles Bibliográficos
Autores principales:	Inshaw, Jamie, Leen, Clifford, Fisher, Martin, Gilson, Richard, Hawkins, David, Collins, Simon, Fox, Julie, McLean, Ken, Fidler, Sarah, Phillips, Andrew, Lattimore, Sam, Babiker, Abdel, Porter, Kholoud
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4520682/ https://www.ncbi.nlm.nih.gov/pubmed/26225723 http://dx.doi.org/10.1371/journal.pone.0132772

Ejemplares similares

An Evaluation of HIV Elite Controller Definitions within a Large Seroconverter Cohort Collaboration
por: Olson, Ashley D., et al.
Publicado: (2014)

Differences in HIV Natural History among African and Non-African Seroconverters in Europe and Seroconverters in Sub-Saharan Africa
por: Pantazis, Nikos, et al.
Publicado: (2012)

Role of HIV Infection Duration and CD4 Cell Level at Initiation of Combination Anti-Retroviral Therapy on Risk of Failure
por: Lodi, Sara, et al.
Publicado: (2013)

The importance of viral blips and duration of therapy initiated in primary infection in maintaining viral control after stopping cART
por: Fidler, Sarah, et al.
Publicado: (2014)

Enhanced normalisation of CD4/CD8 ratio with early antiretroviral therapy in primary HIV infection
por: Thornhill, John, et al.
Publicado: (2014)

Viral Linkage in HIV-1 Seroconverters and Their Partners in an HIV-1 Prevention Clinical Trial
por: Campbell, Mary S., et al.
Publicado: (2011)

Duration of HIV-1 Viral Suppression on Cessation of Antiretroviral Therapy in Primary Infection Correlates with Time on Therapy
por: Stöhr, Wolfgang, et al.
Publicado: (2013)

Brief Report: Enhanced Normalization of CD4/CD8 Ratio With Earlier Antiretroviral Therapy at Primary HIV Infection
por: Thornhill, John, et al.
Publicado: (2016)

Clinical Progression Rates by CD4 Cell Category Before and After the Initiation of Combination Antiretroviral Therapy (cART)
por: Guiguet, Marguerite, et al.
Publicado: (2008)

Virologic and Immunologic Response to cART by HIV-1 Subtype in the CASCADE Collaboration
por: Touloumi, Giota, et al.
Publicado: (2013)

Cytokine cascade and networks among MSM HIV seroconverters: implications for early immunotherapy
por: Huang, Xiaojie, et al.
Publicado: (2016)

Upregulation of PTPRC and Interferon Response Pathways in HIV-1 Seroconverters Prior to Infection
por: Li, Yunqi, et al.
Publicado: (2023)

Brief Report: Sexual Risk Behaviors of HIV Seroconverters in the US Army, 2012–2014
por: Hakre, Shilpa, et al.
Publicado: (2015)

Restriction of V3 region sequence divergence in the HIV-1 envelope gene during antiretroviral treatment in a cohort of recent seroconverters
por: Gall, Astrid, et al.
Publicado: (2013)

HCV-coinfection is related to an increased HIV-1 reservoir size in cART-treated HIV patients: a cross-sectional study
por: López-Huertas, Maria Rosa, et al.
Publicado: (2019)

Protective effect of KIR3DS1 in asymptomatic HIV-1 seroconverters towards AIDS
por: Stalinraja, M, et al.
Publicado: (2012)

Disease progression by infecting HIV-1 subtype in a seroconverter cohort in sub-Saharan Africa
por: Amornkul, Pauli N., et al.
Publicado: (2013)

The risk of AIDS-defining events is decreasing over time in the German HIV-1 Seroconverter Cohort
por: Altmann, Mathias, et al.
Publicado: (2012)

Prevalence and persistence of transmitted drug resistance mutations in the German HIV-1 Seroconverter Study Cohort
por: Machnowska, Patrycja, et al.
Publicado: (2019)

HIV‐1 drug resistance among individuals who seroconverted in the ASPIRE dapivirine ring trial
por: Parikh, Urvi M., et al.
Publicado: (2021)

Plasma HIV Viral Rebound following Protocol-Indicated Cessation of ART Commenced in Primary and Chronic HIV Infection
por: Hamlyn, Elizabeth, et al.
Publicado: (2012)

A qualitative study exploring the social and environmental context of recently acquired HIV infection among men who have sex with men in South-East England
por: Gourlay, Annabelle, et al.
Publicado: (2017)

Duration of Influenza Virus Shedding Among HIV-Infected Adults in the cART Era, 2010–2011
por: Patel, Pragna, et al.
Publicado: (2016)

Attitudes and beliefs towards early ART initiation in MSM with primary HIV infection
por: Parsons, Victoria, et al.
Publicado: (2014)

Mother to child transmission of HIV among Zimbabwean women who seroconverted postnatally: prospective cohort study
por: Humphrey, Jean H, et al.
Publicado: (2010)

Host Genetic Factors Associated with Symptomatic Primary HIV Infection and Disease Progression among Argentinean Seroconverters
por: Coloccini, Romina Soledad, et al.
Publicado: (2014)

HIV and cART-Associated Dyslipidemia Among HIV-Infected Children
por: Tadesse, Birkneh Tilahun, et al.
Publicado: (2019)

Failure to seroconvert after two doses of BNT162b2 SARS-CoV-2 vaccine in a patient with uncontrolled HIV
por: Touizer, Emma, et al.
Publicado: (2021)

Prevalence of Transmitted Drug Resistance and Impact of Transmitted Resistance on Treatment Success in the German HIV-1 Seroconverter Cohort
por: Bartmeyer, Barbara, et al.
Publicado: (2010)

Disease progression of HIV-1 infection in symptomatic and asymptomatic seroconverters in Osaka, Japan: a retrospective observational study
por: Watanabe, Dai, et al.
Publicado: (2015)

Characteristics of HIV seroconverters in the setting of universal test and treat: Results from the SEARCH trial in rural Uganda and Kenya
por: Nyabuti, Marilyn N., et al.
Publicado: (2021)

The Burgeoning HIV/HCV Syndemic in the Urban Northeast: HCV, HIV, and HIV/HCV Coinfection in an Urban Setting
por: Morano, Jamie P., et al.
Publicado: (2013)

Schistosomiasis was not associated with higher HIV-1 plasma or genital set point viral loads among HIV seroconverters from four cohort studies
por: Bochner, Aaron F., et al.
Publicado: (2019)

Diverse HCV Strains And HIV URFS Identified Amongst People Who Inject Drugs In India
por: Rodgers, Mary A., et al.
Publicado: (2020)

Disease progression and mortality with untreated HIV infection: evidence synthesis of HIV seroconverter cohorts, antiretroviral treatment clinical cohorts and population‐based survey data
por: Glaubius, Robert, et al.
Publicado: (2021)

Seroprevalence of HCV, HBV and HIV in two inner-city London emergency departments
por: Cieply, L., et al.
Publicado: (2019)

Acute retroviral syndrome and high baseline viral load are predictors of rapid HIV progression among untreated Argentinean seroconverters
por: Socías, M Eugenia, et al.
Publicado: (2011)

Development of IgG Mediated Antibody Dependent Cell-mediated Cytotoxicity (ADCC) in the Serum and Genital Mucosa of HIV Seroconverters
por: Aziz, Mariam, et al.
Publicado: (2015)

2516. Persistence of Anti-HIV Antibodies in HIV-1-infected Patients on Combination Antiretroviral Therapy (cART) with Prolonged Viral Suppression
por: Singh, Kanal, et al.
Publicado: (2019)

Venue-Based Networks May Underpin HCV Transmissions amongst HIV-Infected Gay and Bisexual Men
por: Bradshaw, Daniel, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_fio5paqb5e367u4fc8c765j6gl